[1] BISCHOFF S C,BOIRIE Y,CEDERHOLM T,et al.Towards a multidisciplinary approach to understand and manage obesity and related diseases[J].Clinical Nutrition,2017,36(4):917-938.
[2] AFSHIN A,FOROUZANFAR M H,REITSMA M B,et al.Health effects of overweight and obesity in 195 countries over 25 years[J].The New England Journal of Medicine,2017,377(1):13-27.
[3] HRUBY A,MANSON J A E,QI L,et al.Determinants and consequences of obesity[J].American Journal of Public Health,2016,106(9):1656-1662.
[4] WORLD HEALTH ORGANIZATION (WHO).Obesity and overweight factsheet from the WHO[J].Health,2017,17(1):124-143.
[5] WANG D,ZHANG Y,LU J,et al.Cordycepin,a natural antineoplastic agent,induces apoptosis of breast cancer cells via caspase-dependent pathways[J]. Natural Product Communications,2016,11(1):63-68.
[6] TULI H S,SANDHU S S,SHARMA A K.Pharmacological and therapeutic potential of cordyceps with special reference to cordycepin[J].Biotech, 2014,4(1):1-12.
[7] ZHOU Y,GUO Z,MENG Q,et al.Cordycepin affects multiple apoptotic pathways to mediate hepatocellular carcinoma cell death[J].Anti-Cancer Agents in Medicinal Chemistry,2017,17(1):143-149.
[8] LEE J B,ADROWER C,QIN C,et al.Development of cordycepin formulations for preclinical and clinical studies[J].American Association of Pharmaceutical Scientists,2017,18(8):3219-3226.
[9] JEONG J W,CHOI Y H.Anti-cancer properties and relevant mechanisms of cordycepin,an active ingredient of the insect fungus Cordyceps spp[J]. Journal of Life Science,2015,25(5):607-614.
[10] MELMED S.The Pituitary[M].The Fourth Edition.NewYork:Academic Press,2017.
[11] BEN-JONATHAN N,HUGO E R,BRANDEBOURG T D,et al.Focus on prolactin as a metabolic hormone[J].Trends in Endocrinology & Metabolism,2006,17(3):110-116.
[12] COSTANZA M,BINART N,STEINMAN L,et al.Prolactin:A versatile regulator of inflammation and autoimmune pathology[J].Autoimmunity Reviews,2015,14(3):223-230.
[13] BERNARD V,YOUNG J,CHANSON P,et al.New insights in prolactin:Pathological implications[J].Nature Reviews Endocrinology,2015,11(5):265-275.
[14] NAEF L,WOODSIDE B.Prolactin/leptin interactions in the control of food intake in rats[J]. Endocrinology,2007,148(12):5977-5983.
[15] FLINT D J,BINART N,KOPCHICK J,et al.Effects of growth hormone and prolactin on adipose tissue development and function[J].Pituitary,2003,6(2):97-102.
[16] PEREZ MILLAN M I,LUQUE G M,RAMIREZ M C,et al.Selective disruption of dopamine D2 receptors in pituitary lactotropes increases body weight and adiposity in female mice[J].Endocrinology,2014,155(3):829-839.
[17] 田孝祥,闫承慧,刘丹,等.黄芪水提取物减轻高脂饮食引起的小鼠肥胖[J].现代生物医学进展,2015,14(34):6629-6632. TIAN X X,YAN C H,LIU D,et al.Astragalus water extract to reduce the obesity of mice caused by high fat diet[J].Modern Biomedical Advances,2015,14(34):6629-6632.(in Chinese)
[18] 张慧,罗帷.蛹虫草中虫草素的研究与开发进展[J].现代农业科技,2016,5(9):292. ZHANG H,LUO W.Research and development of cordycepin[J].Modern Agricultural Science and Technology,2016,5(9):292.(in Chinese)
[19] 刘伟,李鸿雁,颜克松,等.代谢综合征大鼠模型的建立[J].中国畜牧兽医,2015,42(5):1218-1221. LIU W,LI H Y,YAN K S,et al.Establishment of rat model of metabolic syndrome rats[J].China Animal Husbandry & Veterinary Medicine,2015,42(5):1218-1221.(in Chinese)
[20] 和兴萍,罗燕,李雪,等.几种降脂减肥实验动物模型的建立与比较[J].中华中医药学刊,2017,35(7):1747-1751. HE X P,LUO Y,L X,et al.The establishment and comparison of several experimental animal models for reducing fat and weight[J].Journal of Chinese Medicine,2017,35(7):1747-1751.(in Chinese)
[21] 张毅,王洪云,钮福祥,等.'宁紫薯1号'花青素组分鉴定及其对大鼠高脂诱导肥胖的预防效果[J].中国农业科学,2016,49(9):1787-1802. ZHANG Y,WANG H Y,NIU F X,et al.Identification of anthocyanin and its prevention effect on high-fat induced obesity in rats[J].Scientia Agricultura Sinica,2016,49(9):1787-1802.(in Chinese)
[22] 郑丽,侯彩云,任发政.白茶寿眉预防小鼠肥胖作用研究及安全性评价[J].茶叶科学,2017,37(6):586-596. ZHENG L,HOU C Y,REN F Z.Research and safety evaluation on the prevention of obesity in mice with white tea[J].Tea Science,2017,37(6):586-596.(in Chinese)
[23] CARRÉ N,BINART N.Prolactin and adipose tissue[J].Biochemistry and Molecular Biology,2014,2(97):16-21.
[24] BEN-JONATHAN N,HUGO E.Prolactin (PRL) in adipose tissue:Regulation and functions[J].Advances in Experimental Medicine and Biology,2015,846(12):1-35.
[25] LING C,SVENSSON L,ODÉN B,et al.Identification of functional prolactin (PRL) receptor gene expression:PRL inhibits lipoprotein lipase activity in human white adipose tissue[J]. The Journal of Clinical Endocrinology & Metabolism,2003,88(4):1804-1808.
[26] 宗楷淇,马增春,高月.腺苷A1受体的作用研究进展[J].中国药理学通报,2008,24(5):573-576. ZONG K Q,MA Z C,GAO Y.Progress in the role of adenosine A1 receptor[J].Chinese Pharmacological Bulletin,2008,24(5):573-576.(in Chinese)
[27] BURNSTOCK G.Purinergic signalling in endocrine organs[J].Purinergic Signalling,2014,10(1):189-231.
[28] PICANÇO-DINIZ D L,VALENCA M M,ANTUNES-RODRIGUES J.Adenosine A1 receptor-mediated inhibition of in vitro prolactin secretion from the rat anterior pituitary[J].Brazilian Journal of Medical and Biological Research,2006,39(11):1493-1499. |